Afinitor

Novartis Pharmaceuticals Corporation🇺🇸 United States

FDA Page

Effective Date: Jun 1, 2026
Approval ID: 2150f73a-179b-4afc-b8ce-67c85cc72f04
Products: 7 registered
Version: 67

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use AFINITOR/AFINITOR DISPERZ safely and effectively. See full prescribing information for AFINITOR/AFINITOR DISPERZ. AFINITOR (everolimus) tablets, for oral use AFINITOR DISPERZ (everolimus tablets for oral suspension) Initial U.S. Approval: 2009

Quick Stats

Total Products7

Labelers2

Label Sections42

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.